Chester County News and Community Website
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that Steven Kelly, President and CEO, will be participating in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. …
Carisma Therapeutics CEO to Speak at 7th Annual Evercore ISI HealthCONx Conference Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), in collaboration with Moderna, Inc. (Nasdaq: MRNA), has announced promising pre-clinical results for their innovative anti-GPC3 chimeric antigen receptor macrophage (CAR-M) therapy targeting …
Carisma Therapeutics and Moderna Unveil Promising Pre-Clinical Data for Anti-GPC3 CAR-M Therapy Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced its financial results for the third quarter of 2024, alongside significant progress in its clinical and preclinical programs. The company …
Carisma Therapeutics Reports Q3 2024 Results, Advances Clinical Programs Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced a key addition to its Board of Directors with the appointment of Sohanya Cheng, effective October 31, 2024. Concurrently, Michael …
Carisma Therapeutics Welcomes Sohanya Cheng to Board of Directors Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) is set to present significant advancements in cancer treatment at the Society for Immunotherapy of Cancer (SITC) 2024 conference in Houston, Texas, from …
Carisma Therapeutics to Showcase Cutting-Edge Cancer Research at SITC 2024 Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has broadened its collaboration with Moderna, Inc. (Nasdaq: MRNA) to focus on developing treatments for autoimmune diseases, marking a significant step in leveraging …
Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that its President and CEO, Steven Kelly, will be presenting at several significant industry conferences this fall.
Carisma Therapeutics CEO to Present at Key Industry Conferences Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) released its financial results for the second quarter ended June 30, 2024. The company also provided updates on its ongoing clinical and …
Carisma Therapeutics Reports Progress and Financial Results for Q2 2024 Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) announced its participation in the upcoming American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024. The event will …
Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) announced the recent appointment of Marella Thorell and Dr. David Scadden to its Board of Directors, which became effective June 30, 2024. …
Carisma Therapeutics Appoints New Board Members, Strengthens Leadership Read More